Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$203K Sell
5,651
-1,765
-24% -$65.6K ﹤0.01% 2382
2019
Q3
$260K Sell
7,416
-109
-1% -$4.19K ﹤0.01% 2124
2019
Q2
$324K Buy
7,525
+6,166
+454% +$255K ﹤0.01% 1934
2019
Q1
$58K Sell
1,359
-359
-21% -$14.4K ﹤0.01% 3275
2018
Q4
$63K Sell
1,718
-261
-13% -$9.69K ﹤0.01% 3026
2018
Q3
$79K Buy
1,979
+512
+35% +$20.5K ﹤0.01% 2932
2018
Q2
$57K Sell
1,467
-97
-6% -$3.57K ﹤0.01% 2979
2018
Q1
$54K Buy
1,564
+694
+80% +$24.4K ﹤0.01% 3001
2017
Q4
$29K Buy
870
+100
+13% +$3.45K ﹤0.01% 3465
2017
Q3
$25K Sell
770
-148
-16% -$5.1K ﹤0.01% 3436
2017
Q2
$32K Sell
918
-30
-3% -$1.01K ﹤0.01% 3159
2017
Q1
$29K Buy
+948
New +$29.2K ﹤0.01% 3106

Other funds holding QGEN

Advisor Group's QGEN Position: Q4 2019 in Review

Advisor Group reduced its Qiagen (QGEN) stake by 24% in Q4 2019, selling an estimated $65.6K and leaving 5,651 shares worth $203K. The position accounts for ﹤0.01% of the portfolio, ranked #2382.

Advisor Group first reported a position in QGEN in Q1 2017 and has held it in 12 quarters since. The position peaked at $324K in Q2 2019. 296 funds tracked by Wall St. Rank hold QGEN as of Q4 2019.

  • Advisor Group held 5,651 shares of Qiagen worth $203K as of Q4 2019.
  • Advisor Group sold 1,765 Qiagen shares in Q4 2019, an estimated $65.6K.
  • Qiagen made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #2382 holding.
  • Advisor Group first reported a position in Qiagen in Q1 2017 and has held it in 12 quarters since.
  • Advisor Group's Qiagen position peaked at $324K in Q2 2019.
  • 296 funds tracked by Wall St. Rank held Qiagen as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.